CD274 and neoplasm: Some of the receptor/ligand combinations between T-cells and tumor cells are inhibitory in nature such as PD-1/PD-L1 (programmed cell death receptor and ligand) and CTLA-4/B7 (cytotoxic T lymphocyte-antigen 4) [11-14].